June 1, 2008
Cerberus eyes Talecris sale instead of IPO - Financial Times
Cerberus eyes Talecris sale instead of IPO - Financial Times
Talecris Biotherapeutics, the blood plasma products maker that Cerberus Capital filed to take public last year, may instead be sold, according to people familiar with the situation. Cerberus and partner Ampersand Ventures bought Talecris, the former
Texas League report - Northwest Arkansas News
Player s dad gets a bonus Steve Sutton came to watch his son play baseball. He left with a brand-new TV. Sutton, 56, drove from his home in Magnolia to watch his son, Corpus Christi Hooks second baseman Drew Sutton, play against the Arkansas
Cat: | Time: 7:58 am (UTC+8) Edit This